Effector-mediated eradication of precursor B acute lymphoblastic leukemia with a novel Fc engineered monoclonal antibody targeting the BAFF-R

B-cell activating factor receptor (BAFF-R) is expressed on precursor B acute lymphoblastic leukemia ALL (pre-B ALL) cells but not on their pre-B normal counterparts. Thus, selective killing of ALL cells is possible by targeting this receptor. Here we have further examined therapeutic targeting of pr...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Parameswaran, Reshmi, Lim, Min, Fei, Fei, Abdel-Azim, Hisham, Arutyunyan, Anna, Schiffer, Isabelle, McLaughlin, Margaret E., Gram, Hermann, Huet, Heather, Groffen, John, Heisterkamp, Nora
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4067324/
https://ncbi.nlm.nih.gov/pubmed/24825858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-1023
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky